Previous 10 |
TORRANCE, Calif. , Sept. 3, 2019 /PRNewswire/ -- Emmaus Life Sciences, Inc. (Nasdaq: EMMA), a leader in sickle cell disease treatment, announced today the allowance of patent application number 12860587.0, directed to the treatment of diverticulosis, by the European Patent Office. Th...
TORRANCE, Calif. , Aug. 28, 2019 /PRNewswire/ -- Emmaus Life Sciences, Inc. (Nasdaq: EMMA), a leader in sickle cell disease treatment, announced today the addition of Oncology Supply, a part of Amerisource Bergen, as a distributor of its signature product, Endari ® (L-glutamine...
Gainers : Ossen Innovation (NASDAQ: OSN ) +41% . Sears Hometown and Outlet Stores (NASDAQ: SHOS ) +27% . Koss (NASDAQ: KOSS ) +25% . Standex International (NYSE: SXI ) +24% . Caleres (NYSE: CAL ) +23% . Prothena Corporation (NASDAQ: PRTA ) +23% . Town Sports International Holdin...
TORRANCE, Calif. , Aug. 14, 2019 /PRNewswire/ -- Emmaus Life Sciences, Inc. (Nasdaq: EMMA), a leader in sickle cell disease treatment, announced today that the company's Sideline Sickle Cell campaign, led by Emmy Award-winning NFL broadcaster Solomon Wilcots , will host a sickle c...
Emmaus Life Sciences (NASDAQ: EMMA ): Q2 GAAP EPS of -$0.52. Revenue of $5.9M (+129.6% Y/Y) Press Release More news on: Emmaus Life Sciences, Inc., Earnings news and commentary, Healthcare stocks news, ,
TORRANCE, Calif. , Aug. 12, 2019 /PRNewswire/ -- Emmaus Life Sciences, Inc. (Nasdaq: EMMA) , a leader in sickle cell disease treatment, today reported significantly improved financial results at its EMI Holding, Inc. (EMI) subsidiary for the 2019 second quarter and six-months e...
TORRANCE, Calif. , Aug. 8, 2019 /PRNewswire/ -- Emmaus Life Sciences, Inc. (Nasdaq: EMMA), a leader in sickle cell disease treatment, today reiterated the improved balance sheet, reduced debt service and other benefits realized from its recently completed merger transaction an...
Gainers: Aphria (NYSE: APHA ) +36% . Natural Grocers by Vitamin Cottage (NYSE: NGVC ) +33% . BlackLine (NASDAQ: BL ) +29% . Regional Health Properties (NYSEMKT: RHE ) +22% . Griffon Corporation (NYSE: GFF ) +20% . PC Connection (NASDAQ: CNXN ) +19% . Pinterest (NYSE: PINS ) +1...
TORRANCE Calif. , July 29, 2019 /PRNewswire/ -- Emmaus Life Sciences, Inc. (Nasdaq: EMMA), a leader in sickle cell disease treatment, today detailed the improved balance sheet, reduced debt service and other benefits realized from its recently completed merger transaction announced...
News, Short Squeeze, Breakout and More Instantly...
Emmaus Life Sciences Incorporation Company Name:
EMMA Stock Symbol:
NYSE Market:
Emmaus Life Sciences Incorporation Website:
Emmaus Life Sciences Announces Outcome of FDA Inspection of Postmarketing Adverse Drug Experience Compliance Program PR Newswire TORRANCE, Calif. , July 12, 2024 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCPK: EMMA) , a commercial-stage biopharmaceuti...
Emmaus Life Sciences Reports 2023 Financial Results PR Newswire TORRANCE, Calif. , July 3, 2024 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCPK: EMMA) , a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today r...
ADDvantage Technologies Group Inc. (AEYGQ) is expected to report for Q1 2024 ContraFect Corporation (CFRXQ) is expected to report for Q1 2024 American Clean Resources Group Inc (ACRG) is expected to report for Q1 2024 Atlantic Lithium Ltd Ord Fully Paid (ALLIF) is expected to report f...